Cancer and itch

Herbert C. Chiang, Victor Huang, Lynn A. Cornelius

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Itch represents a common and significant source of morbidity in the oncological setting. Itch sometimes can be associated with an underlying malignancy, most commonly leukemia or lymphoma. Alternatively, itch may present secondary to malignant invasion causing hepatic or renal dysfunction. Finally, itch may be related to therapeutic regimens for the underlying malignancy. This article seeks to review the clinical scenarios in which itch affects the oncological patient, to briefly present the latest understanding of the molecular and cellular mechanisms of malignancy-related itch, and to review currently available therapeutic options.

Original languageEnglish (US)
Pages (from-to)107-112
Number of pages6
JournalSeminars in Cutaneous Medicine and Surgery
Issue number2
StatePublished - Jun 1 2011
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Dermatology


Dive into the research topics of 'Cancer and itch'. Together they form a unique fingerprint.

Cite this